LBO — DELRAY MEDICAL CENTER
IRR: 16.2% | MOIC: 2.12x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.2%
IRR
2.12x
MOIC
$595.2M
Entry EV
$883.0M
Exit EV
$306.3M
Equity Invested
Sources & Uses
S&UTotal · $595.2M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $231.2M | 38.8% | |
| Sub Debt | $57.8M | 9.7% | |
| Equity | $306.3M | 51.5% | |
| Enterprise Value | $577.9M | 97.1% | |
| Transaction Fees | $17.3M | 2.9% | |
| Total Uses | $595.2M | 100.0% |
Interpretation
INTAt 2.12x MOIC and 16.2% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $84.1M |
| Exit Ev | $883.0M |
| Net Debt At Exit | $233.9M |
| Equity At Exit | $649.1M |
| Equity Invested | $306.3M |
| Total Value Created | $342.8M |
| Value From Growth | $276.2M |
| Value From Multiple | $28.9M |
| Value From Deleveraging | $55.0M |